# Suzhou Innomed Medical Device Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suzhou-innomed-medical-device-co

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.innomed.com.cn
- Total disclosed funding: $15M
- Latest round: Series C (May 7, 2022)
- Investors on record: 9

## About

Based in Suzhou, China and established in 2013, Suzhou Innomed Medical Device Co., Ltd. focuses on developing and manufacturing implantable medical devices and systems in terms of peripheral vascular stents and venous stents. The company has an ISO13485 certified manufacturing plant with an on-site cleanroom. Its Nitinol wire braided peripheral stent system received the Red Dot design award in 2016. The company's Chairman and CEO, Xiao-Yan Gong graduated from Peking University. In August 2006, he founded Medical Implant Mechanics LLC (MIM), and launch more than a billion dollars of valued products. As of 2022, the company has more than 50 employees.

The company's products can be categorized into interventional medical devices and implantable medical devices. Some main products of medical devices category include Veno Brighet, Inno Hydrowire, Inno Pathwire, and Quick Fenestrater. Its Veno Brighet contains features such as flexible operation, strong passing ability, and small resistance. It is suitable for exfoliation of great saphenous vein or small saphenous without complications and primary various veins or chronic venous insufficiency in patients.

## Funding rounds

- Series C, May 7, 2022, $15M — Yunsong Capital
- Series C, Jun 1, 2020 — Huihe Capital
- Series C, Apr 13, 2020 — Founder H Fund, Tongren Boda Capital
- Series B, Nov 5, 2018 — Share Capital, Taizhou Rongjianda Venture
- Series B, Mar 28, 2017 — Sharewin Investment, Loyal Valley Capital
- Series A, Sep 9, 2015 — Cenova Ventures

## Investors

- Cenova Ventures (https://capitalatlas.ai/funds/cenova-ventures) — Series A
- Sharewin Investment (https://capitalatlas.ai/funds/sharewin-investment) — Series B
- Loyal Valley Capital (https://capitalatlas.ai/funds/loyal-valley-capital) — Series B
- Share Capital (https://capitalatlas.ai/funds/share-capital) — Series B
- Taizhou Rongjianda Venture — Series B
- Founder H Fund (https://capitalatlas.ai/funds/founder-h-fund) — Series C
- Tongren Boda Capital (https://capitalatlas.ai/funds/tongren-boda-capital) — Series C
- Huihe Capital — Series C
- Yunsong Capital (https://capitalatlas.ai/funds/yunsong-capital) — Series C